Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss	$ (7,349,056)	$ (8,488,967)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	1,156,495	1,253,882
Issuance of shares in consulting agreements	0	203,501
Amortization of debt discount	448,837	272,578
Depreciation expense	5,459	5,459
Finance lease depreciation expense	9,670	9,670
Changes in assets and liabilities:
Prepaid expenses and other assets	764,455	(3,395,931)
Accounts payable	75,904	1,174,424
Accrued expenses	516,590	(66,872)
Net cash used in operating activities	(4,371,646)	(9,032,256)
Cash flows from financing activities:
Proceeds from issuance of pre-funded warrants	0	1,009,969
Proceeds from exercise of pre-funded warrants	0	71
Proceeds from issuance of warrants	0	2,150,771
Payments of finance lease obligations	(13,198)	(14,761)
Loan principal repayment	(1,500,000)	(3,125,000)
Proceeds from issuance of common stock from at-the-market program, net of issuance costs	833,371	306,115
Proceeds from issuance of common stock, net of issuance costs	0	6,994,174
Net cash provided by financing activities	(679,827)	7,321,339
Net increase in cash and cash equivalents	(5,051,473)	(1,710,917)
Cash and cash equivalents at beginning of period	26,711,969	41,689,591
Cash and cash equivalents at the end of period	21,660,496	39,978,674
Supplemental information of cash and non-cash transactions:
Cash paid for interest	$ 564,653	$ 693,989